Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
70.38
+4.68 (7.12%)
Aug 13, 2025, 4:00 PM - Market closed
Claritev Market Cap
Claritev has a market cap or net worth of $1.16 billion as of August 14, 2025. Its market cap has increased by 270.73% in one year.
Market Cap
1.16B
Enterprise Value
5.76B
1-Year Change
270.73%
Ranking
Category
Stock Price
$70.38
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $1.16B, an increase of 377.16%. That is a compound annual growth rate of 33.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.16B | 385.13% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |